Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers (scientific article)

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Q35737888

Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

Q35815958

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

Q35940158

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Q35996692

Prediction of breast cancer risk based on profiling with common genetic variants

Q36583004

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

Q36615665

Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk

Q36720814

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

Q36742577

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Q36897003

Identification of personal risk of breast cancer: genetics

Q37039765

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

Q37090813

Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status

Q37223335

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

Q37367871

A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes

Q81725988

P275

Creative Commons Attribution 4.0 International

copyrighted

issue

language of work or name

English

Q1860

P921

main subject

ovarian cancer

Q172341

BRCA1 Mutation

Q28444960

P577

publication date

2017-07-01

P1433

published in

Journal of the National Cancer Institute

Q400279

P1476

title

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

P478

volume

109

Reverse relations

cites work (P2860)

Q92638741	A research-based gene panel to investigate breast, ovarian and prostate cancer genetic risk
Q47564486	Are VNTRs co-localizing with breast cancer-associated SNPs?
Q50042648	Assessing the effectiveness of NICE criteria for stratifying breast cancer risk in a UK cohort.
Q89160515	Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
Q91045517	BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
Q62712290	BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding
Q52586080	Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
Q89746441	Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field
Q47703662	Common Genetic Variation and Breast Cancer Risk - Past, present, and future
Q58808629	Common genetic variants contribute to risk of rare severe neurodevelopmental disorders
Q64042890	Common genetic variants contribute to risk of rare severe neurodevelopmental disorders
Q93039940	Cost-effectiveness of long-term clinical management of BRCA pathogenic variant carriers
Q90575699	Cumulative evidence for relationships between multiple variants of HNF1B and the risk of prostate and endometrial cancers
Q57108215	Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS Analyses
Q47159094	Functional germline variants as potential co-oncogenes
Q64080586	Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer
Q97643246	Genetic architecture of complex traits and disease risk predictors
Q62583135	Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma
Q47900293	Genome-wide association studies of cancer: current insights and future perspectives
Q64236058	Genomic Predictors of Asthma Phenotypes and Treatment Response
Q90460444	Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test
Q47138752	Increased single-strand annealing rather than non-homologous end-joining predicts hereditary ovarian carcinoma
Q92504600	Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women
Q64279327	Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk
Q47714672	Knowledge and Perceptions of Common Breast Cancer Risk Factors in Northern Saudi Arabia
Q58769239	Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls
Q62751549	Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment
Q92784849	Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression
Q48124146	Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells
Q91892103	PRSice-2: Polygenic Risk Score software for biobank-scale data
Q58113261	Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE)
Q62583133	Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q98611548	Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
Q97524107	Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
Q91657211	Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis
Q38857539	Precancer Atlas to Drive Precision Prevention Trials.
Q97423797	Predicting breast cancer risk using interacting genetic and demographic factors and machine learning
Q36356727	Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores
Q92683687	Progress in Polygenic Composite Scores in Alzheimer's and Other Complex Diseases
Q90950265	Quantifying the polygenic contribution to variable expressivity in eleven rare genetic disorders
Q64061836	Recent developments in genetic/genomic medicine
Q92187296	Somatic variants of potential clinical significance in the tumors of BRCA phenocopies
Q63377982	Testing Positive on a Multigene Panel Does Not Suffice to Determine Disease Risks
Q52684293	The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?
Q89856001	The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort
Q88778863	The personal and clinical utility of polygenic risk scores
Q90261670	The transferability of lipid loci across African, Asian and European cohorts